Ciraparantag Completed Phase 1 Trials for Reversal of Edoxaban Induced Anticoagulation / Anticoagulant Reversal Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01826266Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban